Literature DB >> 8167330

Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria.

R E Ware1, W F Rosse, T A Howard.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematologic disorder with multiple and varied clinical manifestations. The biochemical defect in PNH resides in the incomplete enzymatic assembly of glycosylphosphatidylinositol (GPI) anchors used for surface protein attachment. In all patients tested thus far, the defect is at the level of N-acetylglucosamine attachment to phosphatidylinositol (complementation class A defect). A human cDNA, Piga, that repairs cell lines with the class A defect has been recently cloned, making Piga a candidate gene for PNH. In the current study, using highly purified GPI-deficient granulocytes, we have performed Northern blot and reverse transcriptase polymerase chain reaction (RT-PCR) analysis of Piga in four patients with PNH. In each case, we have identified a mutation in the Piga coding sequence: three frameshift mutations were found, and a single nucleotide substitution (missense) mutation was identified. Our results provide convincing evidence that alterations in the Piga gene are responsible for PNH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167330

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria.

Authors:  Jennifer J Johnston; Andrea L Gropman; Julie C Sapp; Jamie K Teer; Jodie M Martin; Cyndi F Liu; Xuan Yuan; Zhaohui Ye; Linzhao Cheng; Robert A Brodsky; Leslie G Biesecker
Journal:  Am J Hum Genet       Date:  2012-02-02       Impact factor: 11.025

2.  Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell.

Authors:  R Tominaga; T Katagiri; K Kataoka; K Kataoka; R K C Wee; A Maeda; H Gomyo; I Mizuno; T Murayama; S Ogawa; S Nakao
Journal:  Leukemia       Date:  2015-10-06       Impact factor: 11.528

3.  Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

Authors:  T O Harville; D M Adams; T A Howard; R E Ware
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

Review 4.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

Authors:  Hudson H Freeze; Jessica X Chong; Michael J Bamshad; Bobby G Ng
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

5.  Therapeutic potential of staphylococcal superantigen-like protein 7 for complement-mediated hemolysis.

Authors:  Yan Li; Fiona Clow; John D Fraser; Feng Lin
Journal:  J Mol Med (Berl)       Date:  2018-07-31       Impact factor: 4.599

6.  Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria.

Authors:  J H Yoon; H I Cho; S S Park; Y H Chang; B K Kim
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

7.  Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism.

Authors:  V C Taylor; M Sims; S Brett; M C Field
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

Review 8.  Rational therapeutic options for patients with myeloproliferative neoplasms.

Authors:  Ronald Hoffman
Journal:  Trans Am Clin Climatol Assoc       Date:  2011

9.  A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload.

Authors:  Kathryn J Swoboda; Rebecca L Margraf; John C Carey; Holly Zhou; Tara M Newcomb; Emily Coonrod; Jacob Durtschi; Kalyan Mallempati; Attila Kumanovics; Ben E Katz; Karl V Voelkerding; John M Opitz
Journal:  Am J Med Genet A       Date:  2013-11-20       Impact factor: 2.802

10.  Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients.

Authors:  A Savoia; L Ianzano; C Lunardi; G De Sandre; M Carotenuto; P Musto; L Zelante
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.